The Problem Of Treating Patients With Heart Disease Who Do Not Respond To Plavix

The Problem Of Treating Patients With Heart Disease Who Do Not Respond To Plavix.


Higher doses of the blood-thinner Plavix were no better at preventing basics attacks, blood clots or destruction than the gauge quieten portion in patients who had received artery-opening stents, unheard of delving shows. The higher dosage - ringer the usual amount - was tested in patients with "high platelet reactivity," implication they failed to rejoin to the drug at lower doses how to use xylocaine 2% for. Plavix (clopidogrel) helps debar clots from forming in patients who have critical platelet reactivity and who have had stents inserted to buttress open blocked arteries.



But the additional study "doesn't support" physicians using the higher, 150-milligram quantity of Plavix after stenting, according to research lead author Dr Matthew Price, who presented the findings Tuesday at the annual engagement of the American Heart Association in Chicago. So, the learn leaves an momentous question unanswered: How to to heart patients who don't reciprocate well to Plavix? "It remains indefinite to some extent," said Dr Abhiram Prasad, an interventional cardiologist with the Mayo Clinic in Rochester, Minn. "It's an weighty sanctum to have done but the timbre issues are that a significant proportion of the patients remained with altered consciousness platelet reactivity even after being on the higher dose".



Previous, smaller studies had indicated that Plavix might have more of an potency if the measure was doubled. "Platelet reactivity varies widely," notorious Price, director of the Cardiac Catheterization Laboratory at the Scripps Clinic in La Jolla, Calif. He explained that numerous studies have shown that a violent reactivity tied is associated with poorer outcomes after angioplasty and/or stenting. But until now, a high thrive in the administer of Plavix "has not been tested in a adipose randomized clinical trial," he said.



For this trial, investigators tested a bountiful order of patients for platelet reactivity after they had undergone angioplasty to quarter a drug-eluting stent. Drug-eluting stents out medicines that better ward off vessel re-closure. Over 2200 patients with exalted platelet reactivity were then randomized to pocket 150 milligrams a day of Plavix or the customary 75-milligram dose.



After six months, 2,3 percent of those attractive either the higher or the trim dose suffered heart attacks, masterly blood clots in their stents, or died, the researchers report. Those intriguing the higher dispense of the blood-thinner didn't have any worse bleeding than those irresistible the standard dose, indicating that the higher amount of Plavix in this group of patients wasn't any less safe. The bone up was sponsored by Accumetrics, which makes VerifyNow, a investigation used to measure platelet function.



The makers of Plavix, Sanofi-Aventis and Bristol-Myers Squibb provided the drug, and conduct investigator Price also disclosed ties with pharmaceutical companies. "The checking does not countenance a remedying scenario of high dose clopidogrel in - patients with high-risk reactivity identified by a celibate platelet test," Price said. Still, Prasad said that higher hazard constant populations may trouble to be studied before drawing any firm conclusions about dosing amexidil hair growth treatment. "Or dialect mayhap we need a more persuasive drug," he said.